Why Novartis Stock Is Down Today Despite Topping Q2 Estimates

Investors were caught off guard by a decision on the research and development front. And yet, Novartis stock is down 4.5% as of 1:55 p.m. ET Thursday, according to data from S&P Global Market Intelligence. One red flag spoils an otherwise solid quarter Novartis is looking for more of the same in the near future. Its previous full-year projection for operating income growth in the low to mid teens was raised to an expectation of growth in the mid to high teens. That's a considerable increase for a company of ...